Ge. Raskob et al., MONITORING LOW-DOSE WARFARIN THERAPY BY A CENTRAL LABORATORY AND IMPLICATIONS FOR CLINICAL-TRIALS AND PATIENT-CARE, The American journal of cardiology, 78(9), 1996, pp. 1074-1076
The central laboratory provides International Normalized Ratio results
in close agreement with the local laboratory for monitoring the antic
oagulant effect of low-dose warfarin. A central laboratory may have pr
actical advantages for patients in rural areas that lack laboratory fa
cilities for anticoagulant monitoring.